Ultrasound-based
sonodynamic therapy
has great potential
for the wireless treatment of human diseases that exploit sound-responsive
materials such as microbubbles, piezoelectric nanoparticles, and molecular
sonosensitizers. Although small molecule-based sonosensitizers are
attractive, their performance needs significant improvement, and a
clear understanding of the origin of the ultrasound-mediated reactive
oxygen species (ROS) generation property is yet to be established.
Here, we have investigated molecular sonosensitizer-loaded poly(ethylene
glycol)–poly(lactide) (PEG–PLA) micelles to investigate
their ROS generation performance in the presence of ultrasound. We
found that molecular sonosensitizers produce singlet oxygen as the
primary ROS component, and the ROS generation performance depends
on the molecular structure and experimental conditions. We propose
that sonoluminescence-induced molecular excitation is associated with
such ROS generation. The nanocarrier-based cell delivery of a molecular
sonosensitizer is shown to generate intracellular ROS under ultrasound
exposure and has been used for cell therapy application. This work
shows that singlet oxygen is primarily responsible for molecular sonosensitizer-based
sonodynamic therapy, and a nanomicelle-based carrier can greatly improve
this therapeutic performance.